Juliana Comerlato

Ms. Juliana Comerlato


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2014 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
JCJuliana Comerlato
Juliana Comerlato
Fabrício S. CamposFabrício S. Campos
Fabrício S. Campos
MOMartha Trindade Oliveira
Martha Trindade Oliveira
SCSamuel Paulo Cibulski
Samuel Paulo Cibulski
LCLilian Corrêa
Lilian Corrêa
AFAna Franco
Ana Franco

26 September 2016 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
JCJuliana Comerlato
Juliana Comerlato
Fabrício S. CamposFabrício S. Campos
Fabrício S. Campos
TST. Souza-Arantes
T. Souza-Arantes
MRM. I. Roos-Kulmann
M. I. Roos-Kulmann
MOMartha Trindade Oliveira
Martha Trindade Oliveira
AFAna Franco
Ana Franco
The human polyomaviruses JC and BK (JCPyV and BKPyV) are ubiquitous, species-specific viruses that belong to the family Polyomaviridae. These viruses are known to be excreted in human urine, and they are potential indicators of human wastewater contamination. In order to assess the distribution of both JCPyV and BKPyV in urban water samples collected from a sewage treatment plant (STP) and from a canalized water stream of Porto Alegre, Brazil, two nested-PCR assays were optimized and applied to the samples collected. The amplicons obtained were submitted to sequencing, and the sequences were analyzed with sequences of human polyomaviruses previously deposited in GenBank. Twelve out of 30 water samples (40%) were JCPyV positive, whereas six samples (20%) were BKPyV positive. The sequencing results confirmed the presence of JCPyV subtypes 1 and 3, whereas only BKPyV Ia and Ib were found. This study shows for the first time the presence of human polyomaviruses in surface water and in samples collected in a sewage treatment plant in southern Brazil.

18 January 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
FSFernando Hayashi Sant'Anna
Fernando Hayashi Sant'Anna
TATiago Finger Andreis
Tiago Finger Andreis
RSRichard Salvato
Richard Salvato
AVAna Paula Muterle Varela
Ana Paula Muterle Varela
JCJuliana Comerlato
Juliana Comerlato
EWEliana Wendland
Eliana Wendland
With the coexistence of multiple lineages and increased international travel, recombination and gene flow are likely to become increasingly important in the adaptive evolution of SARS-CoV-2. These processes could result in genetic introgression and the incipient parallel evolution of multiple recombinant lineages. However, identifying recombinant lineages is challenging, and the true extent of recombinant evolution in SARS-CoV-2 may be underestimated. This study describes the first SARS-CoV-2 Deltacron recombinant case identified in Brazil. We demonstrate that the recombination breakpoint is at the beginning of the Spike gene. The 5′ genome portion (circa 22 kb) resembles the AY.101 (Delta), and the 3′ genome portion (circa 8 kb nucleotides) is most similar to the BA.1.1 (Omicron). Furthermore, evolutionary genomic analyses indicate that the new strain emerged after a single recombination event between lineages of diverse geographical locations in December 2021 in South Brazil. This Deltacron, AYBA-RS, is one of the dozens of recombinants described in 2022. The submission of only four sequences in the GISAID database suggests that this lineage had a minor epidemiological impact. However, the recent emergence of this and other Deltacron recombinant lineages (XD, XF, and XS) suggests that gene flow and recombination may play an increasingly important role in the COVID-19 pandemic. We explain the evolutionary and population genetic theory that supports this assertion, concluding that this stresses the need for continued genomic surveillance. This monitoring is vital for countries where multiple variants are present, as well as for countries that receive significant inbound international travel.

31 May 2018 in Viruses
Verified
Journal Article
Open access
PDF file
LCLucía Cano-Ortiz
Lucía Cano-Ortiz
DJDennis Maletich Junqueira
Dennis Maletich Junqueira
JCJuliana Comerlato
Juliana Comerlato
AZAndré Zani
André Zani
CCCristina Santos Costa
Cristina Santos Costa
AFAna Franco
Ana Franco
Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3; A3) proteins comprise an important family of restriction factors that produce hypermutations on proviral DNA and are able to limit virus replication. Vif, an accessory protein present in almost all lentiviruses, counteracts the antiviral A3 activity. Seven haplotypes of APOBEC3Z3 (A3Z3) were described in domestic cats (hap I–VII), and in-vitro studies have demonstrated that these proteins reduce infectivity of vif-defective feline immunodeficiency virus (FIV). Moreover, hap V is resistant to vif-mediated degradation. However, studies on the effect of A3Z3 in FIV-infected cats have not been developed. Here, the correlation between APOBEC A3Z3 haplotypes in domestic cats and the frequency of hypermutations in the FIV vif and env genes were assessed in a retrospective cohort study with 30 blood samples collected between 2012 and 2016 from naturally FIV-infected cats in Brazil. The vif and env sequences were analyzed and displayed low or undetectable levels of hypermutations, and could not be associated with any specific A3Z3 haplotype.